PND42 COST-EFFECTIVENESS ANALYSIS OF ERENUMAB VERSUS TOPIRAMATE FOR PATIENTS WITH CHRONIC MIGRAINES TO IDENTIFY THE COST-EFFECTIVE PRICE THRESHOLD IN GREECE
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1315
https://www.valueinhealthjournal.com/article/S1098-3015(19)31507-4/fulltext
Title :
PND42 COST-EFFECTIVENESS ANALYSIS OF ERENUMAB VERSUS TOPIRAMATE FOR PATIENTS WITH CHRONIC MIGRAINES TO IDENTIFY THE COST-EFFECTIVE PRICE THRESHOLD IN GREECE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31507-4&doi=10.1016/j.jval.2019.04.1315
First page :
Section Title :
Open access? :
No
Section Order :
10816